Skip to main content
logo
Brii Biosciences Limited (HKG:2137)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.9400
+0.0100 (1.08%)
Jul 31, 2026, 4:08 PM HKT

Brii Biosciences Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6781,0177171,6635,35923,698
Market Cap Growth
-54.65%41.89%-56.90%-68.97%-77.38%-
Enterprise Value
-1,528-1,305-1,880-1,3351,55129,354
Last Close Price
0.941.410.982.287.3732.90

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
17.1525.7113.4927.0138.77208.62
PB Ratio
0.260.390.260.491.505.83
P/TBV Ratio
0.290.440.270.531.565.79

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----11.22258.41

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.010.000.000.01
Net Debt / Equity Ratio
-0.83-0.83-0.88-0.86-0.94-1.01
Net Debt / EBITDA Ratio
6.756.755.714.945.905.53
Net Debt / FCF Ratio
5.675.676.104.476.013.79
Asset Turnover
0.010.010.020.020.040.04
Quick Ratio
60.0260.0229.9721.7013.3312.13
Current Ratio
60.7360.7331.1822.1113.4312.16
Return on Equity (ROE)
-9.09%-9.09%-18.05%-5.92%-15.14%-534.39%
Return on Assets (ROA)
-7.08%-7.08%-8.55%-10.33%-9.17%-15.64%
Return on Capital Employed (ROCE)
-12.30%-12.30%-15.40%-17.70%-16.20%-18.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-36.51%-24.36%-75.46%-11.58%-10.22%-21.57%
FCF Yield
-55.84%-37.26%-55.85%-39.35%-10.47%-4.56%
Buyback Yield / Dilution
1.15%1.15%-0.29%-0.64%-64.78%-129.57%